Copyright Reports & Markets. All rights reserved.

Global Newborn Genetic Screening Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Newborn Genetic Screening Service by Type
    • 1.3.1 Overview: Global Newborn Genetic Screening Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Newborn Genetic Screening Service Consumption Value Market Share by Type in 2025
    • 1.3.3 NGS
    • 1.3.4 Whole Exome Sequencing
    • 1.3.5 Others
  • 1.4 Classification of Newborn Genetic Screening Service by Screening Purpose
    • 1.4.1 Overview: Global Newborn Genetic Screening Service Market Size by Screening Purpose: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Newborn Genetic Screening Service Consumption Value Market Share by Screening Purpose in 2025
    • 1.4.3 Core Condition Screening
    • 1.4.4 Expanded Condition Screening
  • 1.5 Classification of Newborn Genetic Screening Service by Service Model
    • 1.5.1 Overview: Global Newborn Genetic Screening Service Market Size by Service Model: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Newborn Genetic Screening Service Consumption Value Market Share by Service Model in 2025
    • 1.5.3 Public Health Program
    • 1.5.4 Consumer
    • 1.5.5 Others
  • 1.6 Global Newborn Genetic Screening Service Market by Application
    • 1.6.1 Overview: Global Newborn Genetic Screening Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Public Hospitals
    • 1.6.3 Private Hospitals
    • 1.6.4 Others
  • 1.7 Global Newborn Genetic Screening Service Market Size & Forecast
  • 1.8 Global Newborn Genetic Screening Service Market Size and Forecast by Region
    • 1.8.1 Global Newborn Genetic Screening Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Newborn Genetic Screening Service Market Size by Region, (2021-2032)
    • 1.8.3 North America Newborn Genetic Screening Service Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Newborn Genetic Screening Service Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Newborn Genetic Screening Service Market Size and Prospect (2021-2032)
    • 1.8.6 South America Newborn Genetic Screening Service Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Newborn Genetic Screening Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Newborn Genetic Screening Service Product and Solutions
    • 2.1.4 Thermo Fisher Scientific Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 Revvity
    • 2.2.1 Revvity Details
    • 2.2.2 Revvity Major Business
    • 2.2.3 Revvity Newborn Genetic Screening Service Product and Solutions
    • 2.2.4 Revvity Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Revvity Recent Developments and Future Plans
  • 2.3 Quest Diagnostics
    • 2.3.1 Quest Diagnostics Details
    • 2.3.2 Quest Diagnostics Major Business
    • 2.3.3 Quest Diagnostics Newborn Genetic Screening Service Product and Solutions
    • 2.3.4 Quest Diagnostics Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.4 MedGenome
    • 2.4.1 MedGenome Details
    • 2.4.2 MedGenome Major Business
    • 2.4.3 MedGenome Newborn Genetic Screening Service Product and Solutions
    • 2.4.4 MedGenome Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 MedGenome Recent Developments and Future Plans
  • 2.5 Mayo Clinic Laboratories
    • 2.5.1 Mayo Clinic Laboratories Details
    • 2.5.2 Mayo Clinic Laboratories Major Business
    • 2.5.3 Mayo Clinic Laboratories Newborn Genetic Screening Service Product and Solutions
    • 2.5.4 Mayo Clinic Laboratories Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Mayo Clinic Laboratories Recent Developments and Future Plans
  • 2.6 GeneDx
    • 2.6.1 GeneDx Details
    • 2.6.2 GeneDx Major Business
    • 2.6.3 GeneDx Newborn Genetic Screening Service Product and Solutions
    • 2.6.4 GeneDx Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 GeneDx Recent Developments and Future Plans
  • 2.7 PreventionGenetics
    • 2.7.1 PreventionGenetics Details
    • 2.7.2 PreventionGenetics Major Business
    • 2.7.3 PreventionGenetics Newborn Genetic Screening Service Product and Solutions
    • 2.7.4 PreventionGenetics Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 PreventionGenetics Recent Developments and Future Plans
  • 2.8 SYNLAB
    • 2.8.1 SYNLAB Details
    • 2.8.2 SYNLAB Major Business
    • 2.8.3 SYNLAB Newborn Genetic Screening Service Product and Solutions
    • 2.8.4 SYNLAB Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 SYNLAB Recent Developments and Future Plans
  • 2.9 Veritas Genetics
    • 2.9.1 Veritas Genetics Details
    • 2.9.2 Veritas Genetics Major Business
    • 2.9.3 Veritas Genetics Newborn Genetic Screening Service Product and Solutions
    • 2.9.4 Veritas Genetics Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Veritas Genetics Recent Developments and Future Plans
  • 2.10 ARCHIMEDlife
    • 2.10.1 ARCHIMEDlife Details
    • 2.10.2 ARCHIMEDlife Major Business
    • 2.10.3 ARCHIMEDlife Newborn Genetic Screening Service Product and Solutions
    • 2.10.4 ARCHIMEDlife Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 ARCHIMEDlife Recent Developments and Future Plans
  • 2.11 GGA
    • 2.11.1 GGA Details
    • 2.11.2 GGA Major Business
    • 2.11.3 GGA Newborn Genetic Screening Service Product and Solutions
    • 2.11.4 GGA Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 GGA Recent Developments and Future Plans
  • 2.12 Cordlife
    • 2.12.1 Cordlife Details
    • 2.12.2 Cordlife Major Business
    • 2.12.3 Cordlife Newborn Genetic Screening Service Product and Solutions
    • 2.12.4 Cordlife Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Cordlife Recent Developments and Future Plans
  • 2.13 Rainbow Genomics
    • 2.13.1 Rainbow Genomics Details
    • 2.13.2 Rainbow Genomics Major Business
    • 2.13.3 Rainbow Genomics Newborn Genetic Screening Service Product and Solutions
    • 2.13.4 Rainbow Genomics Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Rainbow Genomics Recent Developments and Future Plans
  • 2.14 BGI Genomics
    • 2.14.1 BGI Genomics Details
    • 2.14.2 BGI Genomics Major Business
    • 2.14.3 BGI Genomics Newborn Genetic Screening Service Product and Solutions
    • 2.14.4 BGI Genomics Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 BGI Genomics Recent Developments and Future Plans
  • 2.15 Berry Genomics
    • 2.15.1 Berry Genomics Details
    • 2.15.2 Berry Genomics Major Business
    • 2.15.3 Berry Genomics Newborn Genetic Screening Service Product and Solutions
    • 2.15.4 Berry Genomics Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Berry Genomics Recent Developments and Future Plans
  • 2.16 Annaroad
    • 2.16.1 Annaroad Details
    • 2.16.2 Annaroad Major Business
    • 2.16.3 Annaroad Newborn Genetic Screening Service Product and Solutions
    • 2.16.4 Annaroad Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Annaroad Recent Developments and Future Plans
  • 2.17 Jiajian Medical Testing
    • 2.17.1 Jiajian Medical Testing Details
    • 2.17.2 Jiajian Medical Testing Major Business
    • 2.17.3 Jiajian Medical Testing Newborn Genetic Screening Service Product and Solutions
    • 2.17.4 Jiajian Medical Testing Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Jiajian Medical Testing Recent Developments and Future Plans
  • 2.18 Genesky
    • 2.18.1 Genesky Details
    • 2.18.2 Genesky Major Business
    • 2.18.3 Genesky Newborn Genetic Screening Service Product and Solutions
    • 2.18.4 Genesky Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Genesky Recent Developments and Future Plans
  • 2.19 Weihansi Biomedical Technology
    • 2.19.1 Weihansi Biomedical Technology Details
    • 2.19.2 Weihansi Biomedical Technology Major Business
    • 2.19.3 Weihansi Biomedical Technology Newborn Genetic Screening Service Product and Solutions
    • 2.19.4 Weihansi Biomedical Technology Newborn Genetic Screening Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Weihansi Biomedical Technology Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Newborn Genetic Screening Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Newborn Genetic Screening Service by Company Revenue
    • 3.2.2 Top 3 Newborn Genetic Screening Service Players Market Share in 2025
    • 3.2.3 Top 6 Newborn Genetic Screening Service Players Market Share in 2025
  • 3.3 Newborn Genetic Screening Service Market: Overall Company Footprint Analysis
    • 3.3.1 Newborn Genetic Screening Service Market: Region Footprint
    • 3.3.2 Newborn Genetic Screening Service Market: Company Product Type Footprint
    • 3.3.3 Newborn Genetic Screening Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Newborn Genetic Screening Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Newborn Genetic Screening Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Newborn Genetic Screening Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Newborn Genetic Screening Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Newborn Genetic Screening Service Consumption Value by Type (2021-2032)
  • 6.2 North America Newborn Genetic Screening Service Market Size by Application (2021-2032)
  • 6.3 North America Newborn Genetic Screening Service Market Size by Country
    • 6.3.1 North America Newborn Genetic Screening Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States Newborn Genetic Screening Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Newborn Genetic Screening Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Newborn Genetic Screening Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Newborn Genetic Screening Service Consumption Value by Type (2021-2032)
  • 7.2 Europe Newborn Genetic Screening Service Consumption Value by Application (2021-2032)
  • 7.3 Europe Newborn Genetic Screening Service Market Size by Country
    • 7.3.1 Europe Newborn Genetic Screening Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Newborn Genetic Screening Service Market Size and Forecast (2021-2032)
    • 7.3.3 France Newborn Genetic Screening Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Newborn Genetic Screening Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Newborn Genetic Screening Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Newborn Genetic Screening Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Newborn Genetic Screening Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Newborn Genetic Screening Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Newborn Genetic Screening Service Market Size by Region
    • 8.3.1 Asia-Pacific Newborn Genetic Screening Service Consumption Value by Region (2021-2032)
    • 8.3.2 China Newborn Genetic Screening Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Newborn Genetic Screening Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Newborn Genetic Screening Service Market Size and Forecast (2021-2032)
    • 8.3.5 India Newborn Genetic Screening Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Newborn Genetic Screening Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Newborn Genetic Screening Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Newborn Genetic Screening Service Consumption Value by Type (2021-2032)
  • 9.2 South America Newborn Genetic Screening Service Consumption Value by Application (2021-2032)
  • 9.3 South America Newborn Genetic Screening Service Market Size by Country
    • 9.3.1 South America Newborn Genetic Screening Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Newborn Genetic Screening Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Newborn Genetic Screening Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Newborn Genetic Screening Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Newborn Genetic Screening Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Newborn Genetic Screening Service Market Size by Country
    • 10.3.1 Middle East & Africa Newborn Genetic Screening Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Newborn Genetic Screening Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Newborn Genetic Screening Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Newborn Genetic Screening Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Newborn Genetic Screening Service Market Drivers
  • 11.2 Newborn Genetic Screening Service Market Restraints
  • 11.3 Newborn Genetic Screening Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Newborn Genetic Screening Service Industry Chain
  • 12.2 Newborn Genetic Screening Service Upstream Analysis
  • 12.3 Newborn Genetic Screening Service Midstream Analysis
  • 12.4 Newborn Genetic Screening Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Newborn Genetic Screening Service market size was valued at US$ 903 million in 2025 and is forecast to a readjusted size of US$ 1265 million by 2032 with a CAGR of 5.0% during review period.
    Newborn Genetic Screening Service is a public health and clinical service that tests babies shortly after birth to identify inherited or congenital conditions that may not be obvious at first but can cause serious harm if untreated. It typically involves collecting a small blood sample and, in some programs, additional hearing or heart checks, then analyzing the sample using laboratory methods that detect metabolic, endocrine, hematologic, and genetic disorders. When a screen suggests risk, the service coordinates confirmatory testing, specialist referral, and rapid initiation of treatment or monitoring, while also providing counseling and follow-up so families understand results and next steps.
    The newborn genetic screening service market is characterized by strong policy anchoring, high clinical value, and structurally stable demand driven by universal birth cohorts rather than discretionary utilization. Market growth is shaped less by volume expansion and more by qualitative shifts, including the gradual expansion of screened conditions, the adoption of more advanced molecular methods, and the integration of screening with downstream care coordination and long term follow up. Competitive dynamics favor operators with scale, regulatory credibility, and deep integration into public health systems, creating high entry barriers for new providers while limiting price based competition. At the same time, emerging models such as expanded genomic screening and digital result management introduce opportunities for specialized laboratories and technology partners, suggesting that future differentiation will center on clinical utility, operational reliability, and alignment with public health governance rather than purely on testing throughput.
    This report is a detailed and comprehensive analysis for global Newborn Genetic Screening Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Newborn Genetic Screening Service market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Newborn Genetic Screening Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Newborn Genetic Screening Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Newborn Genetic Screening Service market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Newborn Genetic Screening Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Newborn Genetic Screening Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB, Veritas Genetics, ARCHIMEDlife, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Newborn Genetic Screening Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    NGS
    Whole Exome Sequencing
    Others
    Market segment by Screening Purpose
    Core Condition Screening
    Expanded Condition Screening
    Market segment by Service Model
    Public Health Program
    Consumer
    Others
    Market segment by Application
    Public Hospitals
    Private Hospitals
    Others
    Market segment by players, this report covers
    Thermo Fisher Scientific
    Revvity
    Quest Diagnostics
    MedGenome
    Mayo Clinic Laboratories
    GeneDx
    PreventionGenetics
    SYNLAB
    Veritas Genetics
    ARCHIMEDlife
    GGA
    Cordlife
    Rainbow Genomics
    BGI Genomics
    Berry Genomics
    Annaroad
    Jiajian Medical Testing
    Genesky
    Weihansi Biomedical Technology
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Newborn Genetic Screening Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Newborn Genetic Screening Service, with revenue, gross margin, and global market share of Newborn Genetic Screening Service from 2021 to 2026.
    Chapter 3, the Newborn Genetic Screening Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Newborn Genetic Screening Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Newborn Genetic Screening Service.
    Chapter 13, to describe Newborn Genetic Screening Service research findings and conclusion.

    Buy now